Skip to main content
. 2012 Aug 21;12:132. doi: 10.1186/1472-6882-12-132

Table 2.

Study Visits

  Visit 1
 Daily
 Visit 2
 Visit 3
 Visit 4
 Weekly Phone Calls
 Visit 5
Screening (within 60 days of baseline) Days (−7 to 70) Baseline Week 0 Week 3 Week 6 Week (−1, 1–2, 4–5 & 7–9) Week 10
Laboratory Values 1
 X
  
  
  
  
  
  
Medical Exam/History/Socio-demographics
 X
  
  
  
  
  
  
Urine Pregnancy Test 1
 X
  
  
  
  
  
  
PRIME-MD2
 X
  
  
  
  
  
  
HADS 2
 X
  
  
  
 X
  
 X
BFI 2
 X
  
 X
 X
 X
 X
 X
Concomitant Medication & Supplements
 X
  
  
  
  
  
  
Sleep Diary
 X
  
  
  
 X
  
  
Group Randomization 3
  
  
 X
  
  
  
  
Actiwatch Data Collected
  
 X
 X4
 X4
 X4
  
 X4
LTQL
  
  
 X
  
 X
  
 X
BSAPQ 2
 X
  
 X
  
 X
  
 X
GSE 2
  
  
 X
  
 X
  
 X
BPI2
 X
  
 X
  
 X
  
 X
Study Logbook
  
 X
 X
 X
 X
  
 X
PSQI 2
 X
  
  
  
 X
  
 X
VAS for Pain 2
 X
  
  
  
  
  
  
Berlin Questionnaire
 X
  
  
  
  
  
  
Therapy Evaluation Questionnaire
  
  
 X
  
 X
  
  
Perform Acupressure 5
  
  
 X
 X
 X
  
  
Assess Treatment Fidelity – Self efficacy Measure
  
  
  
 X
 X
  
  
Adverse Events
  
  
  
 X
 X
 X
 X
Assessment of Blinding         X    

1 Complete Blood Count; blood for correlative tests, blood for future DNA analysis, Urine pregnancy test as appropriate.

2 HADS = Hospital Anxiety Depression Scale; BFI = Brief Fatigue Inventory; and PSQI = Pittsburgh Sleep Quality Index; LTQL = Long Term Quality of Life Instrument; BSAPQ = Breast and Surrounding Areas Pain Questionnaire; GSE = General Self Efficacy Scale; BPI = Brief Pain Inventory; VAS for Pain = Visual Analog; PRIME-MD = Primary Care Evaluation of Mental Disorders.

3 Participants are randomized to one of three treatments: Standard of Care; Relaxation Acupressure; or Stimulating Acupressure.

4 Data file downloaded at these visits.

5 Does not apply to standard of care arm.